Koinuma et al., 2005 - Google Patents
Apparent diffusion coefficient measurements with diffusion‐weighted magnetic resonance imaging for evaluation of hepatic fibrosisKoinuma et al., 2005
View PDF- Document ID
- 5614369992372880836
- Author
- Koinuma M
- Ohashi I
- Hanafusa K
- Shibuya H
- Publication year
- Publication venue
- Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine
External Links
Snippet
Purpose To evaluate the use of apparent diffusion coefficient (ADC) measurements based on diffusion‐weighted MRI (DWI) to assess stage of liver disease. Materials and Methods A total of 31 patients who underwent both a liver biopsy and DWI and 132 patients who only …
- 238000009792 diffusion process 0 title abstract description 33
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
- G01R33/56341—Diffusion imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R31/00—Arrangements for testing electric properties; Arrangements for locating electric faults; Arrangements for electrical testing characterised by what is being tested not provided for elsewhere
- G01R31/28—Testing of electronic circuits, e.g. by signal tracer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koinuma et al. | Apparent diffusion coefficient measurements with diffusion‐weighted magnetic resonance imaging for evaluation of hepatic fibrosis | |
Kwee et al. | Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free‐breathing diffusion‐weighted MR imaging of the liver | |
Girometti et al. | Relevance of b‐values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single‐shot spin‐echo echo‐planar diffusion‐weighted sequences | |
Xu et al. | Relationship between the renal apparent diffusion coefficient and glomerular filtration rate: preliminary experience | |
Chow et al. | Liver fibrosis: an intravoxel incoherent motion (IVIM) study | |
Keir et al. | Systematic review of diffusion and perfusion imaging in acute ischemic stroke | |
Tsushima et al. | Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5‐T | |
Bonekamp et al. | Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis | |
Huang et al. | MRI quantification of non‐Gaussian water diffusion in normal human kidney: a diffusional kurtosis imaging study | |
Chung et al. | Magnetic resonance imaging features of ovarian fibroma, fibrothecoma, and thecoma | |
Ichikawa et al. | Intravoxel incoherent motion imaging of focal hepatic lesions | |
Le et al. | Development and evaluation of TWIST Dixon for dynamic contrast‐enhanced (DCE) MRI with improved acquisition efficiency and fat suppression | |
Tan et al. | Magnetic resonance elastography and other magnetic resonance imaging techniques in chronic liver disease: current status and future directions | |
Besa et al. | 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function | |
Besa et al. | Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markers | |
Unal et al. | Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era | |
Mao et al. | Quantitative evaluation of intravoxel incoherent motion diffusion-weighted imaging (IVIM) for differential diagnosis and grading prediction of benign and malignant breast lesions | |
Park et al. | Evaluation of transplanted kidneys using blood oxygenation level–dependent MRI at 3 T: a preliminary study | |
Yamamoto et al. | Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings | |
Koc et al. | Optimal b value in diffusion‐weighted imaging for differentiation of abdominal lesions | |
Wang et al. | Assessment of advanced hepatic MR elastography methods for susceptibility artifact suppression in clinical patients | |
Hu et al. | Assessment of liver fibrosis in rats by MRI with apparent diffusion coefficient and T1 relaxation time in the rotating frame | |
He et al. | Histogram analysis comparison of monoexponential, advanced diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI for differentiating borderline from malignant epithelial ovarian tumors | |
Yang et al. | Staging liver fibrosis in chronic hepatitis B with T1 relaxation time index on gadoxetic acid‐enhanced MRI: Comparison with aspartate aminotransferase‐to‐platelet ratio index and FIB‐4 | |
Emre et al. | Renal function and diffusion-weighted imaging: a new method to diagnose kidney failure before losing half function |